<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Xue Y</submitter><pubmed_abstract>Long noncoding RNAs (lncRNAs) were identified rapidly due to their important role in many biological processes and human diseases including cancer. 1α,25-dihydroxyvitamin D3 [1α,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>] and its analogues are widely applied as preventative and therapeutic anticancer agents. However, the expression profile of lncRNAs regulated by 1α,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub> in ovarian cancer remains to be clarified. In the present study, we found 606 lncRNAs and 102 mRNAs that showed differential expression (DE) based on microarray data. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis indicated that the DE genes were mainly enriched in TGF-β, MAPK, Ras, PI3K-Akt, and Hippo signaling pathways, as well as the vitamin D-related pathway. We f</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>691500</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8377733</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Newly Identified lncBCAS1-4_1 Associated With Vitamin D Signaling and EMT in Ovarian Cancer Cells.</pubmed_title><pmcid>PMC8377733</pmcid><pubmed_authors>Ding H</pubmed_authors><pubmed_authors>Wang P</pubmed_authors><pubmed_authors>Jiang F</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Pei H</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Yu J</pubmed_authors><pubmed_authors>Xue Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Newly Identified lncBCAS1-4_1 Associated With Vitamin D Signaling and EMT in Ovarian Cancer Cells.</name><description>Long noncoding RNAs (lncRNAs) were identified rapidly due to their important role in many biological processes and human diseases including cancer. 1α,25-dihydroxyvitamin D3 [1α,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub>] and its analogues are widely applied as preventative and therapeutic anticancer agents. However, the expression profile of lncRNAs regulated by 1α,25(OH)&lt;sub>2&lt;/sub>D&lt;sub>3&lt;/sub> in ovarian cancer remains to be clarified. In the present study, we found 606 lncRNAs and 102 mRNAs that showed differential expression (DE) based on microarray data. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis indicated that the DE genes were mainly enriched in TGF-β, MAPK, Ras, PI3K-Akt, and Hippo signaling pathways, as well as the vitamin D-related pathway. We f</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-08T05:15:49.757Z</modification><creation>2022-02-11T09:45:15.753Z</creation></dates><accession>S-EPMC8377733</accession><cross_references><pubmed>34422647</pubmed><doi>10.3389/fonc.2021.691500</doi></cross_references></HashMap>